Purpose: turn fragmented campaign data into prioritized, reviewable decisions—not autonomous ad-spend changes.

At a glance

Who it is for: media owners and growth leaders. Expected operating outcome: faster anomaly review and more disciplined testing without autonomous spend changes. Limit: it performs only actions allowed by the approved playbook; sensitive, external, financial, or out-of-policy actions go to a named human owner. Implementation: discovery, scoped connection, limited pilot, then measured expansion.

What this system does

The agent brings together approved media, analytics, and conversion signals to surface anomalies, opportunities, and test recommendations. It explains why a recommendation was made and routes it to the accountable media owner.

Inputs and data sources

  • Approved ad-platform performance data
  • Web analytics and conversion events
  • CRM qualification and revenue signals where available
  • Campaign taxonomy, budget rules, and testing history

Integrations

Connected to approved advertising, analytics, CRM, reporting, and workflow platforms using scoped credentials.

Permitted actions

  • Refresh reports and flag material changes
  • Generate test hypotheses and change proposals
  • Create review tasks and annotate performance context
  • Record approved decisions and outcomes

Human approval gates and escalation

Budget, bid, targeting, creative, tracking, and publishing changes require named human approval. Data-quality issues, policy risk, unusual spend, or missing conversion signals escalate immediately.

Data retention and security posture

The implementation uses only agreed reporting and workflow data. Access, retention, audit trails, and revocation procedures are documented before the pilot begins.

Implementation timeline

  1. Validate measurement and campaign taxonomy.
  2. Connect sources and define alert thresholds.
  3. Run a recommendation-only pilot.
  4. Review decisions and tune the playbook.

KPIs

  • Time from anomaly to review
  • Recommendation acceptance rate
  • Test velocity and learning cycle time
  • Qualified conversion and cost efficiency trends
  • Data freshness and tracking-health exceptions

Evidence and measurement

Results are compared to a documented baseline and reporting window. We publish client cases only with approved, verifiable numbers—not generic ROI claims.

Request an automation and data-readiness review.